Sunridge International Introduces Its New Wholly Owned Subsidiary
January 13 2010 - 9:15AM
PR Newswire (US)
FOUNTAIN HILLS, Ariz., Jan. 13 /PRNewswire-FirstCall/ -- Sunridge
International's (OTC:SNDZ) (BULLETIN BOARD: SNDZ) newly acquired
wholly owned subsidiary Ophthalmic International (OI), is an
innovative manufacturer of medical products. OI has developed and
patented a 2-minute, non-invasive, cost effective, alternative
treatment for glaucoma and ocular hypertension, known as Pneumatic
Trabeculoplasty (PNT). OI holds worldwide patents on the PNT
equipment, its disposable sterile suction ring, as well as the
medical procedure itself. OI having secured 2a CE marketing
approval throughout Europe and Canada is currently marketing its
product line through an exclusive distributor network. Glaucoma is
the second leading cause of blindness, effecting over 70 million
people worldwide. PNT has been proven (through studies completed
over the last 10 yrs) to be a safe and effective treatment with no
adverse side effects, unlike medications usually prescribed to
treat glaucoma that come with a multitude of side effects. For more
information visit our website, http://www.oi-pnt.com/. Contact:
Jeff Smith Phone: 602-363-6344 Email: Forward-looking statements in
this release are made pursuant to the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. Investors are
cautioned that such forward-looking statements involve risks and
uncertainties, including without limitation, continued acceptance
of the company's products, increased levels of competition for the
company, new products and technological changes, the company's
dependence on third-party suppliers, and other risks detailed from
time to time in the company's periodic reports filed with the
Securities and Exchange Commission. DATASOURCE: Sunridge
International CONTACT: Jeff Smith, +1-602-363-6344, , for Sunridge
International Web Site: http://www.oi-pnt.com/
Copyright